Progyny

PGNY

Market cap $2.5B

Melissa B. Cummings disposed of 3,437 shares for a total value of ~$109,000 on July 14, 2026. The transaction reduced the insider's direct equity holdings by 5%.

JBHT, PGNY, BSET, VSXY and PARR stand out for relative price strength, positive estimate revisions and solid fundamentals amid market uncertainty.

Progyny (PGNY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Does Progyny (PGNY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

CFO Mark Livingston sold 8,275 shares for a transaction value of ~$211,000 on May 20, 2026. This represented 9.47% of Livingston's direct holdings, reducing his direct position to 79,063 shares.

Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience Patients increasingly say human connection and advocacy are essential to reducing stress and improving the care experience

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. The program will be funded through available cash balances.

Progyny, Inc. (PGNY) Shareholder/Analyst Call Transcript